40.4: Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns

Pharmacology for Nurses · LibreTexts

0%

Contents

    Text

    Size
    100%
    Theme
    Typeface
    Line length
    Spacing

    From LibreTexts, under CC BY 4.0, as the source states it; its equations are written in TeX, which the PDF shows typeset. This page at LibreTexts.

    40.4: Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns
    Learning Objectives

    By the end of this section, you should be able to:

    • 40.4.1 Identify the characteristics of drugs used to treat miscellaneous dermatologic disorders and burns.
    • 40.4.2 Explain the indications, actions, adverse reactions, and interactions of drugs used to treat miscellaneous dermatologic disorders and burns.
    • 40.4.3 Describe nursing implications of drugs used to treat miscellaneous dermatologic disorders and burns.
    • 40.4.4 Explain the client education related to drugs used to treat miscellaneous dermatologic disorders and burns.

    In addition to acne and psoriasis, there are other common skin conditions for which clients may receive treatment. In this chapter they are divided into miscellaneous dermatologic conditions and burns.

    Miscellaneous Dermatologic Disorders

    This section focuses on the most common dermatological disorders not yet discussed, including cutaneous warts, atopic dermatitis (eczema), contact dermatitis, impetigo, and rosacea.

    Cutaneous Warts

    Cutaneous warts are a form of localized viral infection, resulting in the familiar raised lesions known as warts (Figure 40.5). Current therapies in the treatment of warts include medications that chemically burn these lesions, thus eliminating them. Cantharidin is one such drug. As a vesicant, cantharidin causes local tissue necrosis on those surfaces to which it is applied. This necrosis will eventually result in the sloughing of the wart and elimination of the virus.

    A closeup photo of an eyelid with a wart on it. The wart is a small cluster of rough looking skin.
    Table 40.11 Drug Emphasis Table: Other Dermatologic Drugs (source: https://dailymed.nlm.nih.gov/dailymed/)

    Safety Alert

    Topical Steroids

    When using topical steroids, the application sites should not be covered with an occlusive dressing. Breathable gauze dressings may be used. Topical corticosteroids are meant to exert a local effect; however, when these medications are covered with an occlusive dressing, systemic absorption may occur, leading to systemic side effects of the drug.

    Adverse Effects and Contraindications

    Adverse effects associated with topical medications for skin disorders include hypersensitivities. This is especially associated with mupirocin. Localized irritation, redness, and peeling may be noted with these medications as well. When covered with occlusive dressings, clients may experience systemic absorption, resulting in the likelihood of systemic effects. For this reason, occlusive dressings are contraindicated.

    Steroid compounds are contraindicated in fungal infections. Long-term use of pimecrolimus, a calcineurin inhibitor, has been associated with the development of lymphomas. For this reason, long-term use is contraindicated.

    Table 40.12 is a drug prototype table for common dermatologic medications featuring mupirocin. It lists drug class, mechanism of action, adult and pediatric dosage, indications, therapeutic effects, drug and food interactions, adverse effects, and contraindications.

    Drug Class
    Topical antibiotic

    Mechanism of Action
    Bactericidal; binds RNA transcription
    Drug Dosing
    Adults and children >2 months: Apply ointment (2%) to area 2–3 times daily.
    Indications
    Impetigo

    Therapeutic Effects
    Eradication of impetigo lesions
    Drug Interactions
    Other topical medications used concurrently

    Food Interactions
    No significant interactions
    Adverse Reactions
    Atopic dermatitis
    Contact dermatitis
    Pruritis
    Hypersensitivities including anaphylaxis
    Contraindications
    Hypersensitivity

    Caution:
    Avoid occlusive dressings to prevent systemic
    absorption
    Table 40.12 Drug Prototype Table: Mupirocin (source: https://dailymed.nlm.nih.gov/dailymed/)

    Topical Anti-infectives for Burns

    The greatest risk from minor burns is infection. Because a burn removes layers of skin, an open lesion forms, breaking the skin’s integrity and allowing bacteria and other organisms to enter the client’s body. Silver sulfadiazine and mafenide acetate are two topical anti-infectives used in the treatment and prevention of infection for localized second- and third-degree burns. As with sodium sulfacetamide, these medications are sulfa compounds that should not be administered to those with sulfa allergies. The nurse should take care to maintain a sterile environment when applying these medications to aid in preventing bacterial transfer to the client. To remain effective, burns should be completely covered with cream at all times to prevent bacterial colonization (DailyMed, Sulfamylon, 2023).

    Table 40.13 lists common topical medications used in treating burns with typical routes and dosing for adult and pediatric clients.

    Drug Routes and Dosage Ranges
    Mafenide acetate
    (Sulfamylon)
    Adults and children >2 months: Apply cream once or twice daily, to a thickness of approximately inch.
    Silver sulfadiazine
    (Silvadene)
    Adults and children >2 months: Apply cream once or twice daily, to a thickness of approximately inch.
    Table 40.13 Drug Emphasis Table: Topical Anti-infectives for Burns (source: https://dailymed.nlm.nih.gov/dailymed/)

    Adverse Effects and Contraindications

    Adverse effects associated with topical medications for burns include hypersensitivities, pruritis, localized irritation, redness, and peeling. When covered with occlusive dressings, clients may experience systemic absorption, resulting in the likelihood of systemic effects. For this reason, occlusive dressings are contraindicated. Contraindications include hypersensitivities to drugs or their components.

    Table 40.14 is a drug prototype table for common burn treatments featuring silver sulfadiazine. It lists drug class, mechanism of action, adult and pediatric dosage, indications, therapeutic effects, drug and food interactions, adverse effects, and contraindications.

    Drug Class
    Topical antibiotic

    Mechanism of Action
    Bactericidal; disrupts cell wall
    Drug Dosing
    Adults and children >2 months: Apply cream once or twice daily, to a thickness of approximately inch.
    Indications
    Second- and third-degree burns

    Therapeutic Effects
    Absence of infectious organisms in wound bed
    Drug Interactions
    Other topical medications used concurrently
    Cimetidine

    Food Interactions
    No significant interactions
    Adverse Reactions
    Hypersensitivities
    Necrosis
    Erythema multiforme
    Skin discoloration
    Burning sensation
    Rashes
    Interstitial nephritis
    Leucopenia
    Contraindications
    Hypersensitivity
    Sulfa allergy
    Pregnant clients approaching or at term
    Premature infants or newborn infants during the first 2 months of life
    Table 40.14 Drug Prototype Table: Silver Sulfadiazine (source: https://dailymed.nlm.nih.gov/dailymed/)

    Safety Alert

    Silver Sulfadiazine

    Silver sulfadiazine is widely used for burns with low risk of adverse effects. Overdose is uncommon, but systemic absorption can still occur. Care should be taken when applying the medication near mucosal or ocular areas or when it is used over a large body surface area.

    (Source: Oaks & Cindass, 2023)

    Nursing Implications

    The nurse should do the following for clients who are using drugs for the treatment of burns:

    • Conduct vigilant assessments for baseline, response to treatment, adverse effects, infection, and systemic absorption.
    • Monitor creatinine for decreased renal function from possible effects of systemic absorption.
    • Observe for hypersensitivity reactions during and after administration.
    • Apply topical medications with gloves.
    • Maintain aseptic technique when applying medications.
    • Emphasize the importance of compliance with instructions and follow up with clients when necessary.
    • Provide client teaching regarding the drug and when to call the health care provider. See below for client teaching guidelines.

    Client Teaching Guidelines

    The client using a topical medication for burns should:

    • Take prescribed medications exactly as directed.
    • Wash hands well before and after application.
    • Report side effects such as skin redness, excessive dryness, or peeling to the primary provider.
    • Report drainage, odor, temperature above 100.4°F, or other unusual symptoms to the primary provider.
    • Cleanse skin thoroughly before applying medication.
    • Avoid contact with eyes and mucous membranes.

    The client using a topical medication for burns should not:

    • Cover the medication with occlusive dressings.

    FDA Black Box Warning

    Pimecrolimus

    Pimecrolimus cream has been associated with skin malignancies and lymphoma. Continuous long-term use should be avoided in any age group. Its use is not indicated for children less than 2 years of age.

    Case Study

    Read the following clinical scenario to answer the questions that follow.

    Within the last year, Melissa Allen, a 27-year old patient, has gotten married, moved to a new city, and begun graduate school. Recently, she has noticed feeling a little more tired than usual and has experienced generalized joint pain.

    History
    Right ankle fracture
    Seasonal sinusitis

    Current Medications
    Ibuprofen, 400 mg every 4 hours as needed
    Yasmin birth control pill (drospirenone 3 mg/ethinyl estradiol 0.03 mg)

    Vital Signs Physical Examination
    Temperature: 97.4°F
    • Head, eyes, ears, nose, throat (HEENT): Denies any changes in vision; responds to questions appropriately without requests for repeats
    • Neurological: Alert and oriented × 4, pleasant affect; denies numbness, tingling, dizziness, or headache
    • Cardiovascular: Regular heart rate and rhythm; denies palpitations; S1, S2 audible; no extra sounds noted; capillary refill +3; mucous membranes pink, moist, and intact
    • Respiratory: Lungs clear to auscultation in all fields; denies shortness of breath
    • GI: Abdomen soft, nontender, without distention; bowel sounds active in all quadrants; denies nausea, vomiting, diarrhea, or constipation
    • GU: Last menstrual period 16 days ago
    • Integumentary: Nails with cracking noted; scalp with excessive silvery scaling and reddened areas noted; skin intact to limbs and trunk except for small scaling; red areas noted bilaterally on elbows; client states she has noticed more “itching and dandruff” lately
    Blood pressure: 126/64 mm Hg
    Heart rate: 88 beats/min
    Respiratory rate: 14 breaths/min
    Oxygen saturation: 100% on room air
    Pain: 3/10
    Height: 5'5"
    Weight: 144 lb
    Table 40.15
    Exercise \(\PageIndex{1}\)

    Based on Melissa’s subjective and objective assessment data, what diagnosis should the nurse anticipate from the health care provider?

  1. Acne vulgaris
  2. Psoriasis
  3. Impetigo
  4. Rosacea
  5. Answer

    Psoriasis

    Exercise \(\PageIndex{2}\)

    The health care provider prescribes topical coal tar. Which statement by Melissa indicates a need for further teaching from the nurse regarding the use of topical coal tar?

  6. “I guess this means that I will need to cancel my tanning bed membership.”
  7. “I should cover the surrounding margins of lesions with a thick coat of medication.”
  8. “I will wash my skin, apply the medication, and leave it open to the air.”
  9. “I will refrain from using the medication on my face, especially near my eyes.”
  10. Answer

    “I should cover the surrounding margins of lesions with a thick coat of medication.”


    This page titled 40.4: Other Dermatologic Condition Drugs and Topical Anti-infectives for Burns was last modified on Sun, 29 Dec 2024 09:21:37 GMT and is shared under a CC BY 4.0 license and was authored, remixed, and/or curated by OpenStax.